These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 36525706)

  • 21. Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.
    Das CK; Jena BC; Banerjee I; Das S; Parekh A; Bhutia SK; Mandal M
    Mol Pharm; 2019 Jan; 16(1):24-40. PubMed ID: 30513203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomes Interactions with the Blood-Brain Barrier: Implications for Cerebral Disorders and Therapeutics.
    Osaid Z; Haider M; Hamoudi R; Harati R
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery.
    Elliott RO; He M
    Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33477972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functionalized exosome harboring bioactive molecules for cancer therapy.
    Kim YK; Choi Y; Nam GH; Kim IS
    Cancer Lett; 2020 Oct; 489():155-162. PubMed ID: 32623071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bibliometric and visualized analysis of the applications of exosomes based drug delivery.
    Wei B; Huang H; Cao Q; Song X; Zhang Z
    Biomed Pharmacother; 2024 Jul; 176():116803. PubMed ID: 38788602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Trends in Nanotechnology Toward CNS Diseases: Lipid-Based Nanoparticles and Exosomes for Targeted Therapeutic Delivery.
    Cardoso AM; Guedes JR; Cardoso AL; Morais C; Cunha P; Viegas AT; Costa R; Jurado A; Pedroso de Lima MC
    Int Rev Neurobiol; 2016; 130():1-40. PubMed ID: 27678173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential in exosome-based targeted nano-drugs and delivery vehicles for posterior ocular disease treatment: from barriers to therapeutic application.
    Peng X; Zhang T; Liu R; Jin X
    Mol Cell Biochem; 2024 Jun; 479(6):1319-1333. PubMed ID: 37402019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted exosome-based nanoplatform for new-generation therapeutic strategies.
    Yin W; Ma H; Qu Y; Wang S; Zhao R; Yang Y; Guo ZN
    Biomed Mater; 2024 Mar; 19(3):. PubMed ID: 38471163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomes as drug delivery vehicles and biomarkers for neurological and auditory systems.
    Mittal R; Bencie N; Langlie J; Mittal J; Eshraghi AA
    J Cell Physiol; 2021 Dec; 236(12):8035-8049. PubMed ID: 34224589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application.
    Yang Q; Li S; Ou H; Zhang Y; Zhu G; Li S; Lei L
    J Nanobiotechnology; 2024 Jan; 22(1):41. PubMed ID: 38281957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of exosomes in central nervous system tissue regeneration and repair.
    Wang J; Yang L
    Biomed Mater; 2023 Jul; 18(5):. PubMed ID: 37399812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of Biomembrane-mimetic Nanoparticles for the Treatment of Ischemic Stroke].
    Fukuta T
    Yakugaku Zasshi; 2021; 141(9):1071-1078. PubMed ID: 34471008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-derived nanovesicle-mediated drug delivery to the brain: Principles and strategies for vesicle engineering.
    Liang Y; Iqbal Z; Lu J; Wang J; Zhang H; Chen X; Duan L; Xia J
    Mol Ther; 2023 May; 31(5):1207-1224. PubMed ID: 36245129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies.
    Xu M; Feng T; Liu B; Qiu F; Xu Y; Zhao Y; Zheng Y
    Theranostics; 2021; 11(18):8926-8944. PubMed ID: 34522219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into Exosome Transport through the Blood-Brain Barrier and the Potential Therapeutical Applications in Brain Diseases.
    Abdelsalam M; Ahmed M; Osaid Z; Hamoudi R; Harati R
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo.
    Jia G; Han Y; An Y; Ding Y; He C; Wang X; Tang Q
    Biomaterials; 2018 Sep; 178():302-316. PubMed ID: 29982104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges.
    Cano A; Muñoz-Morales Á; Sánchez-López E; Ettcheto M; Souto EB; Camins A; Boada M; Ruíz A
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.